SCHEMBL477898

SCHEMBL477898

FC1CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2286275 1.00 ALDH1A1 (0.36)
SCHEMBL812284 1.00 ALDH1A1 (0.36)
SCHEMBL61403 1.00
SCHEMBL2282523 1.00 ALDH1A1 (0.36)
SCHEMBL1711109 1.00
SCHEMBL10282692 1.00 ALDH1A1 (0.36)
SCHEMBL2283214 1.00 ALDH1A1 (0.36)
SCHEMBL19219867 1.00
SCHEMBL22790683 1.00 ALDH1A1 (0.36)
SCHEMBL63204 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180008523-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-11 US claimed
US-20180000937-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-04 US claimed
US-20170361078-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-21 US claimed
US-20170354616-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
US-20170354815-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
US-7998615-B2 A fluorohydrocarbon and a room-temperature molten salt consisting of an onium cation and a non-aluminate anion; fireproofing; suppression of a viscosity rise; quality; crystal growth inhibtors; double-layer capacitor operational at low-temperature; secondary batteries including a lithium salt/carbonate PANASONIC CORPORATION (JP) 2011-08-16 US claimed
EP-2133895-A1 Nonaqueous electrolyte for electrochemical devices Panasonic Corporation (JP) 2009-12-16 EP claimed
EP-1557899-B1 Nonaqueous electrolyte for electrochemical devices PANASONIC CORP (JP) 2009-11-25 EP claimed
EP-2044192-A2 ENHANCED OXYGEN CELL CULTURE PLATFORMS University of Miami (US) 2009-04-08 EP claimed
WO-2008006104-A2 ENHANCED OXYGEN CELL CULTURE PLATFORMS UNIVERSITY OF MIAMI (US) 2008-01-10 WO claimed
US-20080009027-A1 Enhanced Oxygen Cell Culture Platforms UNIVERSITY OF MIAMI (US) 2008-01-10 US claimed
CN-1322626-C Nonaqueous electrolyte for electrochemical devices MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 2007-06-20 CN claimed
EP-1557899-A2 Nonaqueous electrolyte for electrochemical devices MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-07-27 EP claimed
US-20050158623-A1 Nonaqueous electrolyte for electrochemical devices MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2005-07-21 US claimed
CN-1641922-A Nonaqueous electrolyte for electrochemical devices MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 2005-07-20 CN claimed
US-20250009652-A1 COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS PEARL THERAPEUTICS, INC. 2025-01-09 US disclosed
US-20240252439-A1 PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE AND USE FOR MANUFACTURING PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE HUNG MING CHIEN (TW) 2024-08-01 US disclosed
WO-1999016419-A9 PERFORATED MICROPARTICLES AND METHODS OF USE ALLIANCE PHARMA (US) 1999-08-19 WO disclosed
WO-1999016422-A1 STABILIZED PREPARATIONS FOR USE IN METERED DOSE INHALERS INHALE THERAPEUTIC SYSTEMS, INC. (US) 1999-04-08 WO disclosed
WO-1999016419-A1 PERFORATED MICROPARTICLES AND METHODS OF USE INHALE THERAPEUTIC SYSTEMS, INC. (US) 1999-04-08 WO disclosed